Skip to content
Politically.com Search all
Menu

2026 · 2nd Quarter (Apr 1 - June 30)

ABBOTT LABORATORIES

Filed by MARSHALL & POPP, LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 9, 2026
Income
$60,000.00
Expenses
Not reported
Filing UUID
146ad32b-2bca-4861-9edf-c9f71780e040
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

AGR · Agriculture

Issues related to infant formula, including H.R. 2300 - To ensure national uniformity with respect to certain requirements relating to preterm infant formula.

Literal federal measure citations: H.R. 2300

MMM · Medicare/Medicaid

Proposals related to Medicare coverage of continuous glucose monitors. Issues related to cancer diagnostics national coverage determination.

TAX · Taxation/Internal Revenue Code

H.R.3512 - Tackling Predatory Litigation Funding Act.

Literal federal measure citations: H.R.3512

DEF · Defense

Issues related to TRICARE coverage of diabetes management devices.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.